Cryo Cell International (CCEL) Cost of Revenue (2010 - 2026)

Cryo Cell International (CCEL) has reported Cost of Revenue for 17 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cost of Revenue fell 9.69% year-over-year to $1.7 million; the TTM figure through May 2026 stood at $6.9 million (down 9.67% YoY), while the FY2025 annual figure was $7.4 million, down 7.19% from the prior year.
• Cost of Revenue rose to $1.7 million in Q2 2026 per CCEL's latest filing, from $1.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.3 million in Q3 2022 and bottomed at $1.6 million in Q4 2024.
• Historically, Cost of Revenue has averaged $2.0 million across 5 years, with a median of $2.0 million in 2024.
• Annual changes were most pronounced in 2024 — Cost of Revenue decreased 19.13% — and 2025, when it increased 5.95%.
• Cryo Cell International's Cost of Revenue stood at $2.1 million in 2022, then fell by 5.38% to $2.0 million in 2023, then fell by 19.13% to $1.6 million in 2024, then gained by 5.95% to $1.7 million in 2025, then declined by 3.31% to $1.7 million in 2026.
• Business Quant data shows CCEL's Cost of Revenue at $1.7 million in Q2 2026, $1.7 million in Q1 2026, and $1.7 million in Q4 2025.